| human | Q5 |
| P227 | GND ID | 1257105116 |
| P2671 | Google Knowledge Graph ID | /g/11f0z1_btc |
| P1960 | Google Scholar author ID | n8iU92MAAAAJ |
| P6634 | LinkedIn personal profile ID | jonine-figueroa-77866098 |
| P496 | ORCID iD | 0000-0002-5100-623X |
| P1153 | Scopus author ID | 16021981100 |
| P4012 | Semantic Scholar author ID | 145917271 |
| P214 | VIAF ID | 2131165271178810690003 |
| P2002 | X username | JonineF |
| P27 | country of citizenship | United States of America | Q30 |
| P108 | employer | University of Edinburgh | Q160302 |
| National Cancer Institute | Q664846 | ||
| Division of Cancer Epidemiology and Genetics, National Cancer Institute | Q45134916 | ||
| P734 | family name | Figueroa | Q21487824 |
| Figueroa | Q21487824 | ||
| Figueroa | Q21487824 | ||
| P106 | occupation | cancer epidemiologist | Q114859104 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | female | Q6581072 |
| Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
| Q28943348 | A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3 |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
| Q28943367 | A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci |
| Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
| Q46949960 | A novel functional variant in 8q24 is associated with regulation of prostate stem cell antigen (PSCA) gene expression and bladder cancer risk |
| Q34678278 | A robust association test for detecting genetic variants with heterogeneous effects |
| Q37599352 | A role for XRCC2 gene polymorphisms in breast cancer risk and survival |
| Q34414220 | A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q34024799 | A versatile protein microarray platform enabling antibody profiling against denatured proteins |
| Q34472668 | Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium |
| Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
| Q33730347 | Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors |
| Q37484995 | Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue |
| Q30779634 | Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases |
| Q36073563 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression |
| Q46949065 | An unusual suspect: an uncommon human-specific synonymous coding variant within the UGT1A6 gene explains a GWAS signal and protects against bladder cancer |
| Q24170413 | Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types |
| Q36245614 | Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers |
| Q35681656 | Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis |
| Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
| Q33781177 | Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies |
| Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q38794059 | Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast |
| Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
| Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
| Q40513376 | Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q112717774 | Associations of fecal microbial profiles with breast cancer and nonmalignant breast disease in the Ghana Breast Health Study |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
| Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
| Q34782282 | Benign breast tissue composition in breast cancer patients: association with risk factors, clinical variables, and gene expression |
| Q36916852 | Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q39734134 | Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States |
| Q98947030 | Breast cancer gene expression datasets do not reflect the disease at the population level |
| Q33622597 | Breast cancer in Sub-Saharan Africa: opportunities for prevention |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q36545335 | Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study |
| Q34158093 | Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression |
| Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
| Q24169697 | Characterization of large structural genetic mosaicism in human autosome |
| Q37305467 | Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression |
| Q36592089 | Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease |
| Q35098777 | Circulating sex hormones and terminal duct lobular unit involution of the normal breast |
| Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
| Q91013280 | Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer. |
| Q36944260 | Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer |
| Q35882541 | Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk |
| Q33829174 | Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q28388475 | Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations |
| Q30660858 | Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer |
| Q35686728 | Cytoplasmic estrogen receptor in breast cancer |
| Q35009790 | DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations |
| Q37685729 | DNA mismatch repair gene MSH6 implicated in determining age at natural menopause |
| Q38907016 | Design considerations for identifying breast cancer risk factors in a population-based study in Africa |
| Q23916196 | Detectable clonal mosaicism and its relationship to aging and cancer |
| Q40554538 | Differential effects of the Ski-interacting protein (SKIP) on differentiation induced by transforming growth factor-beta1 and bone morphogenetic protein-2 in C2C12 cells |
| Q37231038 | Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1. |
| Q96577447 | Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data |
| Q96428998 | Distinguishing between direct and indirect consequences of covid-19 |
| Q55110745 | E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. |
| Q87374141 | ERβ splice variant expression in four large cohorts of human breast cancer patient tumors |
| Q34670325 | Emerging Concepts in Breast Cancer Risk Prediction |
| Q91882304 | Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018 |
| Q57202568 | Erratum: Corrigendum: Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk |
| Q34133476 | Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer |
| Q51766497 | Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation. |
| Q53332557 | Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. |
| Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
| Q34157940 | Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q39063047 | Factors contributing to delays in diagnosis of breast cancers in Ghana, West Africa |
| Q27908479 | Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome |
| Q34158088 | Fine mapping of 14q24.1 breast cancer susceptibility locus |
| Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
| Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q114182808 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element |
| Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
| Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
| Q34520370 | GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis |
| Q33320978 | Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival |
| Q40137431 | Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium |
| Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
| Q29417068 | Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study |
| Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q35559023 | Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland |
| Q46642326 | Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q57568620 | Genetic variation in the base excision repair pathway and bladder cancer risk |
| Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
| Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q36807462 | Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q28659283 | Genome-wide association study identifies multiple loci associated with bladder cancer risk |
| Q35061252 | Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q28943359 | Genome-wide interaction study of smoking and bladder cancer risk |
| Q96432094 | Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk |
| Q34158129 | Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q36547888 | Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers |
| Q37121271 | High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q50064953 | Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer. |
| Q36754771 | Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q23924183 | Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33 |
| Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q30910707 | Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients |
| Q91126083 | Involution of Breast Lobules, Mammographic Breast Density and Prognosis Among Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer Patients |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
| Q33275297 | Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk |
| Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q34158058 | Large-scale genotyping identifies a new locus at 22q13.2 associated with female breast size |
| Q34125066 | Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background |
| Q30575708 | Likelihood ratio test for detecting gene (G)-environment (E) interactions under an additive risk model exploiting G-E independence for case-control data |
| Q97568897 | Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis |
| Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
| Q35856276 | Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q104512328 | Might changes in diagnostic practice explain increasing incidence of brain and central nervous system tumours? A population-based study in Wales (UK) and the US |
| Q36361883 | Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms |
| Q100453965 | Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK |
| Q28393244 | Mosaic loss of chromosome Y is associated with common variation near TCL1A |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
| Q37632955 | Nonsteroidal anti-inflammatory drugs and other analgesic use and bladder cancer in northern New England |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
| Q34486353 | Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status |
| Q112572520 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes |
| Q37329008 | Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer development |
| Q34008159 | Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade |
| Q37307937 | Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium |
| Q36873786 | Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium |
| Q36029610 | Plasma Autoantibodies Associated with Basal-like Breast Cancers |
| Q36831883 | Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q99609978 | Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast |
| Q44032172 | Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies |
| Q37434877 | Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer |
| Q34282820 | Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain |
| Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
| Q92055460 | Prediction and clinical utility of a contralateral breast cancer risk model |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q37223335 | Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status |
| Q91832507 | Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts |
| Q37350137 | Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups |
| Q37531336 | Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland |
| Q34250104 | Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q35116218 | Quantitative Analysis of TDLUs using Adaptive Morphological Shape Techniques |
| Q35677744 | Quantitative assessment of miR34a as an independent prognostic marker in breast cancer |
| Q36009422 | RAD51B in Familial Breast Cancer |
| Q64110313 | Recruiting population controls for case-control studies in sub-Saharan Africa: The Ghana Breast Health Study |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q39800526 | Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy |
| Q37593548 | Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients |
| Q36669402 | Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities |
| Q33815747 | Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer |
| Q90259542 | Reply to 'Mosaic loss of chromosome Y in leukocytes matters' |
| Q89753406 | Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population-based case–control study |
| Q45951126 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. |
| Q34182602 | Reproductive windows, genetic loci, and breast cancer risk |
| Q57611127 | Response |
| Q36545934 | SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival |
| Q52688935 | Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank. |
| Q34158134 | Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women |
| Q50084676 | Skin Lighteners and Hair Relaxers as Risk Factors for Breast Cancer: Results from the Ghana Breast Health Study |
| Q31140460 | Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project |
| Q40637174 | Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study |
| Q35038651 | TGF-β signaling pathway and breast cancer susceptibility |
| Q58047341 | TNF polymorphisms and prostate cancer risk |
| Q33566957 | TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer |
| Q34354399 | Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology |
| Q34372389 | The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease |
| Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q30234451 | The Relationship between Type 2 Diabetes and Breast Cancer Incidence in Differing Ethnic Groups |
| Q35781316 | The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients |
| Q33454487 | The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the "molecular histology" of the breast |
| Q37237634 | The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk |
| Q24296646 | The human Ski-interacting protein functionally substitutes for the yeast PRP45 gene |
| Q90611335 | The relationship between terminal duct lobular unit features and mammographic density among Chinese breast cancer patients |
| Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
| Q95603632 | Trends in excess cancer and cardiovascular deaths in Scotland during the COVID-19 pandemic 30 December 2019 to 20 April 2020 |
| Q35624103 | Tumor intrinsic subtype is reflected in cancer-adjacent tissue. |
| Q115209628 | Tumor-Associated Stromal Cellular Density as a Predictor of Recurrence and Mortality in Breast Cancer: Results from Ethnically Diverse Study Populations |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q93009131 | Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches |
| Q43158472 | Unraveling genes, hormones, and breast cancer |
| Q35456563 | Urinary bisphenol A-glucuronide and postmenopausal breast cancer in Poland |
| Q28917124 | Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data |
| Q62089510 | Winners curse correction and variable thresholding improve performance of polygenic risk modeling based on summary-level data from genome-wide association studies |
| Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
| Jonine Figueroa | wikipedia |
Search more.